A Phase I Study of ADB116 for Injection in Healthy Chinese Adults. This study aims as follows:
Primary Objective:
• To evaluate the safety and tolerability of a single intravenous bolus dose of ADB116 for injection in healthy Chinese adults.
Secondary Objective:
• To evaluate the pharmacokinetic (PK) profile of a single intravenous bolus dose of ADB116 for injection.
Inclusion Criteria:
yunxm@aidea.com.cn+86 0514-87752666
ADB116 for Injection 0.03mg/kg, single intravenous bolus injection
ADB116 for Injection 0.06mg/kg, single intravenous bolus injection
ADB116 for Injection 0.12mg/kg, single intravenous bolus injection
ADB116 for Injection 0.18mg/kg, single intravenous bolus injection
ADB116 for Injection 0.24 mg/kg, single intravenous bolus injection
yangbing@aidea.com.cn+86 025-83193180
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AK0406 Injection in Healthy Adult Participants
Safety and Tolerability of BDB-001 Injection in Healthy Subjects
A Clinical Study of AK0610
Tolerability and Safety of BDB-001 Injection in Healthy Subjects
A Clinical Study of BG136 Injection in Healthy Chinese Volunteers
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZKLJ02 Injection in Healthy Chinese Research Participants
A Study of NBL-012 in Healthy Chinese Subjects
A Single- and Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of THDBH120 Injection in Healthy Subjects